Oral Nitrite Trial for Hypertension and Metabolic Syndrome
Status:
Withdrawn
Trial end date:
2021-04-13
Target enrollment:
Participant gender:
Summary
The objective of the study is to investigate effects of inorganic sodium nitrite on the
cardiometabolic and hormonal disturbances observed in a targeted population of
overweight/obese adults with metabolic syndrome and hypertension, at risk for insulin
resistance and endothelial dysfunction.